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Maternal  nutrition  can  have a signiﬁcant  effect  on  developmental  processes  during  preg-
nancy  and lactation.  While  certain  ﬂavonoids  have  been  postulated  to be  beneﬁcial  for
health,  little  is  known  about  the effects  of ingestion  during  pregnancy  and  lactation  on  the
mother  and progeny.  We  report  on the  effects  of  maternal  consumption  of high  levels  of  cer-
tain ﬂavonoids  on  reproductive  and  developmental  outcomes  in  a mouse  model.  C57BL/6J
female  mice  were  fed a control  diet  (CT),  the CT  diet  supplemented  with  1% or  2%  of  a  mix
of epicatechin  and  catechin  (EC1,  EC2),  or rutin  (RU1,  RU2)  prior  to,  during  pregnancy,  and
lactation.  A  subset  of dams  was  killed  on  gestation  day  (GD)  18.5 to evaluate  fetal  outcomes
and  the  remainder  was  allowed  to  deliver  to evaluate  offspring.  Maternal  food  intake,  body
and  tissue  weight  did not  differ  among  groups.  The  number  of resorptions,  implantations,
litter  size,  postnatal  survival,  body  weight,  and  skeletal  development  were  also  similar.
Alterations  in  maternal  and  offspring  liver  mineral  concentrations  were  observed.  The  cur-evelopment
hemical compounds studied in this article:
−)-Epicatechin (PubChem CID: 24894431)
+)-Catechin hydrate (PubChem CID:
4278298)
utin-hydrate (PubChem CID: 24899379)
rent  results  indicate  that  consumption  of high  amounts  of  epicatechin,  catechin,  and rutin
during  gestation  and  lactation  is  not  associated  with  any marked  developmental  effects,
although  changes  in  liver  mineral  concentrations  were  noted.
©  2015  Published  by  Elsevier  Ireland  Ltd.  This  is  an open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Abbreviations: ANOVA, analysis of variance; CT, control diet; EC1, control di
ontrol diet supplemented with 1% mix  of (−)-epicatechin and (+)-catechin; EG
reen  tea catechins; GTE, green tea extract; PND, postnatal day; RU1, control die
utin;  SEM, standard error of the means; TBHQ, tertiary butylhydroquinone.
∗ Corresponding author at: Children’s Hospital Oakland Research Institute, 570
el.:  +1 510 428 3885x4783; fax: +1 510 428 3284.
E-mail addresses: mnrhenderson@berkeley.edu (M.N.R. Lesser), clkeen@ucdav
http://dx.doi.org/10.1016/j.toxrep.2015.01.003
214-7500/© 2015 Published by Elsevier Ireland Ltd. This is 
http://creativecommons.org/licenses/by-nc-nd/4.0/).et supplemented with 1% mix  of (−)-epicatechin and (+)-catechin; EC2,
CG, epigallo-catechin-gallate; GD, gestation day; GTC-H, heat sterilized
t supplemented with 1% rutin; RU2, control diet supplemented with 2%
0 Martin Luther King Jr. Way, Oakland, CA 94609, United States.
is.edu (C.L. Keen), llanoue@ucdavis.edu (L. Lanoue).
an open access article under the CC BY-NC-ND license
ology R
artery in heparinized syringes and the plasma was  recov-
ered by centrifugation (1500 × g for 15 min  at 4 ◦C), and444 M.N.R. Lesser et al. / Toxic
1. Introduction
Flavonoids are polyphenolic phytochemicals found in a
variety of food items and beverages that are grouped into
six classes characterized by different chemical structures
and physiological properties [1,2]. Data from numer-
ous epidemiological studies support the concept that the
chronic consumption of ﬂavonoid-rich diets can be asso-
ciated with a reduced risk for certain chronic diseases,
including cardiovascular, neurodegenerative and select
cancers [3–8]. In this context, two subclasses of ﬂavonoids,
the ﬂavonols and the ﬂavanols have received particular
attention. Flavonols are found in foods and beverages such
as onions, leeks, broccoli, cherry tomatoes, red wine, and
tea. Rutin (quercetin-3-rhamnosyl glucoside) is a ﬂavonol
glycoside composed of quercetin and the disaccharide ruti-
nose. Rutin has been postulated to have anticarcinogenic
and vasoprotective activities [9–11]. Flavanols or ﬂavan-3-
ols, including the epicatechin and catechin monomers, are
widely consumed in teas, red grapes, red wines, apples and
cocoa-based products. Similar to ﬂavonols, the ﬂavanols
have been reported to have vasoprotective properties
including anti-inﬂammatory and vasodilatory activities
[12–16].
With respect to putative health beneﬁts of ﬂavanols
and ﬂavonols, results from epidemiological and interven-
tion studies have been largely positive [1,7,15,17–19].
While interest in the potential health beneﬁts of ﬂavonoid
intake is considerable, the potential adverse effects of
consuming very large amounts of these phytochemi-
cals have not been extensively studied. Many ﬂavonoids
are available for purchase as dietary supplements, and
it is feasible to achieve levels of intake that markedly
exceed what is provided in typical diets. Given that
these compounds can have pleiotropic effects, and they
have been shown to modulate many cellular activi-
ties, including gene expression, cell signaling, enzymatic
activity, etc.,  further examination of their potential neg-
ative effects when consumed at high levels is warranted
[1,20–22].
The current literature on the physiological conse-
quences of excessive and chronic consumption, speciﬁcally
in the context of pregnancy and developmental toxicity of
these nutrients is limited. Current literature suggests that
there is controversy on whether or not the consumption
of all ﬂavonoids during pregnancy is safe or detrimental
to developmental processes. Some of these reports come
from observations of impaired fetal development (heart,
genitourinary and limb anomalies), impaired absorption
and metabolism of other nutrients, and persistent lasting
effects such as increased risk of early onset of diseases
(for example acute childhood leukemia) [23–32]. While
the above studies supplemented diets with ﬂavonoid-rich
foods or ﬂavonoid preparations, there have been few stud-
ies investigating the effects of the chronic consumption of
speciﬁc ﬂavonoids during pregnancy. In the current paper,
we tested the hypothesis that the prolonged consumption
of high amounts of three ﬂavonoids (epicatechin, catechin,
and rutin) during pregnancy and lactation would result
in adverse fetal and neonatal development in a mouse
model.eports 2 (2015) 443–449
2. Materials and methods
2.1. Materials
Puriﬁed (−)-epicatechin, (+)-catechin hydrate, and
rutin-hydrate, were purchased from Sigma (St. Louis, MO).
2.2. Animals and diets
Virgin, 5-week old C57BL/6J female mice (Jackson Lab-
oratory, Sacramento, CA) were randomly assigned to one
of the ﬁve diets (n = 11–12 per group): a semi-puriﬁed con-
trol (CT) diet; the CT diet supplemented with a ﬂavanol
mixture of epicatechin: catechin, in a 4:1 ratio at 1% of the
diet (8000 mg  epicatechin + 2000 mg  catechin/kg diet; EC1)
or 2% of the diet (16,000 mg  epicatechin + 4000 mg cate-
chin/kg diet; EC2); or the CT diet supplemented with rutin
at 1% of the diet (10,000 mg  rutin/kg diet; RU1) or at 2% of
the diet (20,000 mg  rutin/kg diet; RU2). The ﬂavanol ratio of
4:1 (−)-epicatechin/(+)-catechin reﬂects the ratio reported
in cocoa-containing products [33,34]. Diets were isocaloric
and prepared in small batches containing tertiary butylhy-
droquinone (Dyets, Bethlehem, PA), to minimize oxidation
of the ﬂavonoids.
Female mice were fed their respective diets for 3
weeks prior to breeding. Females were bred overnight with
C57BL/6J males fed a commercial stock diet (Purina, Labo-
ratory Rodent Diet 5001). Breeding was  conducted daily for
a maximum of 2 weeks or until successful mating, as deter-
mined by the presence of a vaginal plug in the morning
(designated gestation day (GD) 0.5). One group of pregnant
dams continued to receive their respective diets through
pregnancy until GD 18.5, at which time the dams were
killed and their litters collected and examined as described
below. The remainder of the dams were transferred to
maternity cages on GD 16.5 and monitored for delivery.
These dams received their respective diets until postnatal
day (PND) 21. During this time, food intake was monitored
weekly. Litter size was recorded and litters were randomly
reduced to eight pups per dam on PND 4. On PND 21, pups
were weaned and housed by sex and dams were killed.
PND 21 offspring continued to be housed in the mater-
nity cages and were fed the diets that corresponded to
their maternal treatment. Pup growth and mortality were
recorded weekly until PND 60. On PND 42, pups were indi-
vidually housed in suspended stainless steel cages and food
intake was  recorded weekly until PND 60. The offspring
were killed on PND 60 and select tissues (liver, heart, lungs,
kidneys, and brain) and plasma were collected. This study
was  approved by the Animal Care and Use Administrative
Advisory Committee of the University of California at Davis.
2.3. Tissue and plasma collection
Dams were killed on GD 18.5, or allowed to deliver
and killed on PND 21. Dams were killed by CO2 inhalation
and exsanguination. Blood was  collected from the femoralstored at −80 ◦C. Tissues were weighed, snap-frozen in liq-
uid nitrogen and stored at −80 ◦C. For GD 18.5 dams, the
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terus was removed and the number of implantation sites
nd resorptions were recorded. All fetuses were isolated
nd weights were recorded. Fetuses were examined for
ross dysmorphology. At PND 60, the offspring were killed
nd blood and tissues were collected as described above.
.4. Tissue mineral concentrations
Maternal and offspring liver samples were prepared for
ineral analysis as described by Clegg et al. [35]. Zinc, iron,
opper, manganese, and calcium concentrations were mea-
ured using ICP spectrophotometry (ICP-AES, Trace Scan,
hermo-Jarrell Ash, Franklin, MA).
.5. Skeletal staining
On PND 42, one male and one female from each litter
ere processed for skeletal examination using a double
taining standard protocol [36]. Brieﬂy, the pups were
illed by CO2 inhalation and then skinned, eviscerated with
orceps, washed, and dehydrated in 95% ethanol for sev-
ral days; transferred to acetone for 48 h to remove fat,
nd then placed in a staining solution (0.3% (w/v) alcian
lue in 70% ethanol, 0.1% (w/v) alizarin red in 95% ethanol,
cetic acid, 70% ethanol) for 3 days. Skeletons were subse-
uently cleared in 1% potassium hydroxide for 48 h. Before
xamination, the samples were transferred to solutions of
lycerin at graded concentrations of 20%, 50% and 80% for
 week each, and stored in 100% glycerol. Skeletal analyses
ncluded counting the number of ribs, sternum, vertebrae
nd examining the arm bones (scapula, humerus, radius,
lna) and leg bones (femur, tibia, ﬁbula) for abnormalities.
.6. Statistical analysis
Statistical analyses were performed using Small Stata
ersion 11.2 (StataCorp, College Station, TX). Signiﬁcant
ffects of maternal dietary treatments on reproductive and
ostnatal outcomes and on maternal and offspring liver
ineral concentrations were determined by analyses of
ariance (ANOVA). Signiﬁcant effects of offspring dietary
reatments on postnatal body weight were determined
y repeated measures ANOVA. Post hoc analysis was per-
ormed to evaluate the signiﬁcance of observed differences
mong the groups using the Tukey method.
Data are expressed as mean ± standard error of the
eans (SEM); statistical signiﬁcance was set at P < 0.05.
. Results
.1. Maternal parameters
Average daily food intake before and during gestation
as similar among the treatment groups (data not shown).
eight gain was similar among the groups, with the largest
ncreases occurring during gestation (data not shown).
here were no differences among GD 18.5 and PND 21
aternal tissue weights (liver, heart, brain, kidney, lungs)
ither on a relative (tissue/body weight ratio) or abso-
ute tissue weight basis (data not shown). Liver samplesports 2 (2015) 443–449 445
from dams killed at GD 18.5 were assessed for zinc, man-
ganese, copper, iron, and calcium concentrations (Table 1).
Signiﬁcant differences were observed for zinc copper, and
calcium. Speciﬁcally, the RU2 group had higher zinc con-
centrations than the CT, EC1, and EC2 groups, higher copper
concentrations than the CT and EC2 groups and higher cal-
cium concentrations than the CT and RU1 groups.
3.2. Reproductive parameters
GD18.5 fetal and placental weights were similar among
the treatment groups (Table 2). There were no differences
in the number of implantation sites or resorptions per lit-
ter across the treatment groups (Table 2). No fetal gross
dysmorphology or fetal death was noted in any treatment
group.
3.3. Postnatal parameters
There were no signiﬁcant differences among treatment
groups for litter size, number of males and females per litter
(Table 3). There was 100% survival from PND 0 until PND
4 and only one EC2 litter and one RU2 litter lost two pups
from PND 4 to PND 60.
Although not signiﬁcant, the EC1 group had the smallest
litter size due to one litter only containing two pups.
3.4. Offspring parameters
Weekly food intake of the offspring was  similar among
groups during each week of food intake data collection
(PND 42–48, PND 49–55, and PND 56–60), when expressed
per litter as well as per sex (data not shown). Body
weights were similar among treatment groups over time
from PND 21 through PND 60 (data not shown). There
were no differences among PND 60 offspring liver, brain,
and lungs tissue weight on a relative (tissue/body weight
ratio) or absolute tissue weight basis (Table 4). Relative
kidney weight was  signiﬁcantly different among groups
(P < 0.001), but absolute weights were similar (Table 4).
Speciﬁcally, EC1 offspring had a larger relative kidney
weight than the CT, RU1, and RU2 groups. Absolute and
relative heart weight was  signiﬁcantly different between
treatment groups (Table 4); speciﬁcally, absolute heart
weight of the offspring in the RU2 group was  lower than
the EC1 group. Relative heart weight of the RU2 group was
lower than the CT, EC1, and EC2 groups. Liver samples from
offspring killed at PND 60 were assessed for zinc, man-
ganese, copper, iron, and calcium concentrations (Table 5).
Signiﬁcant differences were observed for copper, iron and
calcium; speciﬁcally, the EC1 and EC2 groups had lower
copper concentrations than the CT. The EC2 group also
had lower liver iron concentrations than the CT group. The
RU1 and RU2 groups had lower liver calcium concentra-
tions than the CT group. None of the PND 42 skeletonsshown). At PND42 bone calciﬁcation was  completed and
offspring from all groups showed residual cartilage at the
nose, ear, tip of the sternum, and in between the rib
bones.
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Table 1
GD 18.5 maternal liver weight and mineral concentrations.
GD 18.5 CT (n = 5) EC1 (n = 6) EC2 (n = 7) RU1 (n = 7) RU2 (n = 6)
Liver weight (g) 1.8 ± 0.2 1.9 ± 0.1 2.0 ± 0.1 1.7 ± 0.1 1.8 ± 0.1
Zinc  (nmol/g) 407.3 ± 16.6a 401.2 ± 9.9a 387.8 ± 18.9a 454.4 ± 21.6ab 516.2 ± 31.3b
Manganese (nmol/g) 20.3 ± 1.9 20.1 ± 0.7 18.1 ± 1.4 18.3 ± 1.0 21.2 ± 2.6
Copper (nmol/g) 79.0 ± 7.1a 103.4 ± 12.1ab 95.4 ± 13.8a 115.9 ± 8.2ab 153.2 ± 15.2b
Iron (nmol/g) 671.6 ± 61.0 679.4 ± 41.4 698.6 ± 51.2 663.9 ± 63.5 735.1 ± 52.0
Calcium (nmol/g) 682.1 ± 35.9a 746.1 ± 36.1ab 732.4 ± 31.1ab 691.5 ± 32.6a 864.1 ± 52.6b
Values are mean ± SEM; values not sharing the same superscripts are signiﬁcantly different at P < 0.05.
Table 2
Reproductive parameters from GD 18.5 litters.
Diet Number of implantation sites/litter Number of resorptions/litter Fetal weight (g) Placenta weight (g)
CT 9.3 ± 1.5 1.0 ± 0.6 1.13 ± 0.06 0.11 ± 0.03
EC1 8.6 ± 0.4 0.0 ± 0.00 1.07 ± 0.07 0.11 ± 0.01
EC2 7.9 ± 1.0 0.9 ± 0.2 1.17 ± 0.03 0.10 ± 0.01
RU1 8.0 ± 0.7 0.9 ± 0.5 1.11 ± 0.03 0.14 ± 0.03
RU2 9.0 ± 0.5 0.8 ± 0.5 0.98 ± 0.07 0.10 ± 0.01
Values are mean ± SEM.
Table 3
Average litter size and number of males and females per litter, recorded on PND 60.
Diet Litter size Number of males/litter Number of females/litter
CT (n = 3 litters) 7.3 ± 0.7 4.3 ± 0.3 3.0 ± 0.6
EC1 (n = 4 litters) 5.8 ± 1.4 2.5 ± 0.5 3.3 ± 1.3
EC2 (n = 3 litters) 7.0 ± 0.6 3.0 ± 0.0 4.0 ± 0.6
RU1 (n = 4 litters) 7.5 ± 0.3 3.5 ± 0.4 4.0 ± 0.2
RU2 (n = 3 litters) 7.3 ± 0.7 3.7 ± 0.4 3.7 ± 0.8
Values are mean ± SEM.
Table 4
PND 60 offspring liver, heart, brain, kidney, and lung tissue weight.
Diet Absolute weight (g)
Liver Heart Brain Kidney Lungs
CT 0.85 ± 0.03 0.14 ± 0.01ab 0.37 ± 0.01 0.17 ± 0.01 0.16 ± 0.01
EC1 0.88 ± 0.07 0.15 ± 0.01a 0.38 ± 0.01 0.19 ± 0.01 0.17 ± 0.01
EC2 0.89 ± 0.05 0.14 ± 0.00ab 0.39 ± 0.01 0.17 ± 0.01 0.15 ± 0.01
RU1 0.91 ± 0.04 0.14 ± 0.01ab 0.39 ± 0.01 0.17 ± 0.01 0.16 ± 0.01
RU2 0.91 ± 0.08 0.12 ± 0.01b 0.38 ± 0.01 0.18 ± 0.01 0.15 ± 0.01
Diet  Relative weight (%)
Liver Heart Brain Kidney Lungs
CT 4.39 ± 0.12 0.74 ± 0.03a 1.92 ± 0.08 0.85 ± 0.03a 0.81 ± 0.04
EC1 4.54 ± 0.36 0.75 ± 0.03a 1.97 ± 0.06 0.99 ± 0.04b 0.85 ± 0.03
EC2 4.71 ± 0.23 0.72 ± 0.02a 2.12 ± 0.09 0.91 ± 0.04ab 0.81 ± 0.03
RU1 4.39 ± 0.18 0.66 ± 0.02ab 1.91 ± 0.07 0.80 ± 0.02a 0.75 ± 0.03
RU2 4.32 ± 0.21 0.60 ± 0.02b 1.88 ± 0.09 0.82 ± 0.04a 0.76 ± 0.05
Values are mean ± SEM; values not sharing the same superscripts are signiﬁcantly different at P < 0.05.
Table 5
PND 60 offspring liver weight and trace mineral concentrations.
PND60 CT (n = 6) EC1 (n = 8) EC2 (n = 8) RU1 (n = 8) RU2 (n = 6)
Liver weight (g) 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0
Zinc  (nmol/g) 416.2 ± 9.4 382.2 ± 15.7 387.5 ± 8.8 392.4 ± 13.9 324.4 ± 63.9
Manganese (nmol/g) 17.9 ± 0.3 15.8 ± 0.1 18.7 ± 1.8 14.9 ± 1.2 18.0 ± 1.7
Copper (nmol/g) 98.6 ± 6.6a 75.5 ± 6.0b 71.9 ± 3.9b 79.5 ± 2.4ab 82.0 ± 4.9ab
Iron (nmol/g) 2334.0 ± 244.7a 1948.2 ± 124.6ab 1676.3 ± 140.4b 1850.2 ± 55.9ab 1901.3 ± 87.0ab
Calcium (nmol/g) 989.8 ± 125.5a 787.9 ± 30.8ab 818.8 ± 46.4ab 724.4 ± 25.7b 731.2 ± 11.3b
Values are mean ± SEM; values not sharing the same superscripts are signiﬁcantly different at P < 0.05.
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. Discussion
The present study explored the extent to which high
oncentrations of epicatechin and catechin or rutin in the
iet during pregnancy, lactation and postnatal periods
ffects reproductive and developmental processes in an
n vivo mouse model. The rationale for a focus on these three
avonoids was that these three are being actively studied
ith respect to their potential health beneﬁts. Current evi-
ence of the metabolism and transfer of ﬂavonoids to the
etus during pregnancy indicates that the ﬂavanols, or more
ccurately their metabolites, are able to reach fetal tissues,
here they could potentially interact with developmen-
al processes [37,38]. Chu et al. [37] measured detectable
mounts of catechins and catechin gallate derivatives in
ost fetal tissues within the ﬁrst hour following the oral
avage of a moderate dose of a green tea extract (GTE) in
D15.5 rat dams. Maternal plasma concentrations of cate-
hins were approximately 50–100 times higher than that
easured in the fetus and fetal catechins were detectable
ver a 20 h period, suggesting limited excretion capacity.
In our study, we did not observe any adverse effects
f high-dose epicatechin, catechin or rutin in the mater-
al diet on fetal growth and development. This absence of
bservable adverse effects in this in vivo study is in seeming
ontrast with previous in vitro reports [39,40]. However,
ne explanation for a difference in ﬁndings between in vivo
nd in vitro studies is that ﬂavonoids are extensively and
apidly metabolized by the liver (i.e., methylation, sulfona-
ion, and/or glucuronidation), which likely modulate the
ellular bioavailability of these compounds, altering their
hemical properties and limiting their biological activity
41–45]. Others have observed nominal reproductive tox-
city of ﬂavonoids. Logsdon et al. reported no negative
ffects on fertility, fetal weight, or prenatal development
hen CD-1 mice were gavaged 400 or 800 mg/kg/day green
ea extract (GTE) alone (contains epigallo-catechin-gallate
EGCG) ﬂavonoid), from gestation days six through thirteen
ith the exception of an adverse effect on eyelid develop-
ent; fetal eyelid abnormalities were not observed in our
tudy [46]. In the above study, moderate maternal dosages
f GTE (200 mg/kg/day) mitigated the embryotoxic effects
f maternal cyclophosphamide intraperitoneal injection on
D10 [46]. Morita et al. [47] also reported no detrimental
ffects on fertility and fetal growth in rats following the
rogastric administration of graded doses of heat-sterilized
reen tea catechins (GTC-H) in dams between GD 6 to
D 17, daily. Similarly, Isbrucker et al. [48] reported no
ifference in fetal weight or incidence of external, vis-
eral, or skeletal malformations when Wistar rat dams
ere fed a standard powdered diet supplemented with
pigallo-catechin-gallate (EGCG) daily between GD 6–20
t 0, 100, 300, and 1000 mg/kg/day. A limited number of
tudies have examined the reproductive consequences of
avonols during pregnancy. Prater et al. [49] reported no
igniﬁcant adverse reproductive effects of low or high dose
uercetin (a rutin aglycone) in pregnant C75BL/6 mice.
D14 weights of fetuses from dams fed low or high dose
uercetin were similar to those of fetuses of dams fed
 control diet. In this study, quercetin seemed to limit
he developmental damage caused by the reproductiveports 2 (2015) 443–449 447
toxicant methylnitrosourea. Similar quercetin embryotox-
icity preventing effects have been reported in a whole
embryo culture model using hydroxurea as the insult agent
[50].
Postnatal survival and body weight in our study were
not affected. In contrast, Isbrucker et al. [48] reported a
signiﬁcant increase in postnatal death during PND 5–21
in the ﬁrst and second-generation offspring (compared to
the control group) when pregnant rats were fed a standard
powdered diet mixed with an EGCG product at approx-
imately 300 and 1000 mg  ECGC/kg/day from GD 6–20
for two  generations. While a difference in body weight
between treatment groups was not observed at any time
point in our study, Isbrucker reported that both male and
female F1 rats in the 1000 mg  EGCG/kg/day group had
lower weight gains and absolute mean body weights com-
pared to the control throughout the course of the study
[48]. The differing results for tissue weight observed in
our study compared to observations reported by Isbrucker
may  be attributed to the animal model used (mice versus
rats) as well as the use of EGCG compared to the speciﬁc
monomeric compounds used in our study.
The consumption of high amounts of ﬂavonoids has
been reported to alter mineral metabolism [1]. This is
thought to be due to the ability of the carboxylic and
hydroxylic groups of ﬂavonoids to form complexes with
metal cations, thus decreasing the amount available for tis-
sue uptake [51]. In addition, ﬂavonoids that can increase
metal-binding proteins, such as metallothionein, could
have secondary effects on mineral status [30]. An increase
in metallothionein in tissue during pregnancy, leading to
the sequestration of minerals such as zinc and copper, can
reduce the amount of minerals available for uptake by
the fetus [52]. We  observed increased liver zinc and cop-
per concentrations, in the RU2-fed pregnant dams only. Of
interest though is that heart tissue weight (absolute and
relative) of the RU2 offspring was  smaller compared to
some of the other treatment groups. This is important to
note as a limited availability of minerals, such as copper,
during developmental processes can have lasting, detri-
mental outcomes [53–55].
In contrast, the observations reported for the offspring
showed that compared to CT, copper levels were approxi-
mately 25% lower in the EC1 and EC2 groups and iron levels
were 28% lower in the EC2 group. Both rutin groups were
similar to controls. Kuo et al. [30] reported an interaction
between catechin and copper resulting in a decrease in cop-
per concentration in cultured human intestinal cells. This
interaction was  also observed between catechin and iron
concentration. The consumption of ﬂavonoid-rich tea, cof-
fee, and cocoa has also been reported to inhibitor of iron
absorption in adults [56]. Previous reports of lower calcium
levels in the offspring of RU treated dams were not found.
The high ﬂavonoid diets were well tolerated among
all study treatment groups and there were no differ-
ences in the amount of food consumed per treatment
group. In order to compare ﬂavonoid intake in our study
to that of other species including humans, we calcu-
lated intake based on metabolic body size [57,58]. In our
study, the ﬂavonoid intake during gestation was approx-
imately 693.9 mg/kg3/4/day (EC1), 1215.7 mg/kg3/4/day
ology R
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(EC2), 665.2 mg/kg3/4/day (RU1), and 1243.8 mg/kg3/4/day
(RU2). The amount of ﬂavonoids ingested during ges-
tation in our study is high compared to the amount
provided in other studies [47,48]. Morita et al. gavage-
administered GTC-H to Sprague Dawley rats during the
second week of gestation. The ﬂavanols, catechin and
epicatechin, contributed 12% of the GTC-H that was  admin-
istered, resulting in a ﬂavanol intake of 57.7 mg/kg3/4/day,
176.9 mg/kg3/4/day, and 297.8 mg/kg3/4/day for the 200,
600, and 2000 mg/kg/day dose groups, respectively [47].
Using ﬂavonoid intake based on metabolic body size,
the human equivalent consumption of the amount of
ﬂavonoids consumed by the mice during gestation in
this study would be approximately 0.09 mg/kg3/4/day
(EC1), 0.18 mg/kg3/4/day (EC2), 0.08 mg/kg3/4/day (RU1),
and 0.17 mg/kg3/4/day (RU2) for a human weighing 70 kg.
It is difﬁcult to compare the intake of ﬂavonoids in
this study to typical human intake, as there is con-
siderable variability in reported intakes. Estimated total
ﬂavonol intake has been reported at approximately
0.53–2.6 mg/kg3/4/day and total ﬂavanol intake at approx-
imately 0.16–4.96 mg/kg3/4/day [1]. In the Iowa Women’s
Study, Mink et al. reported ﬂavonol intake of participants at
the highest quintile to range from 0.62 to 1.07 mg/kg3/4/day
and ﬂavanol (including procyanidins) intake to from 5.58
to 43.39 mg/kg3/4/day. Even if these are estimations that
include all ﬂavonoids, the ﬂavonoid intake in our study
greatly exceeds these reports of human ingestion.
5. Conclusions
In summary, the data from this study show that
the chronic consumption of maternal diets containing
high amounts of ﬂavanols (epicatechin and catechin) or
ﬂavonols (rutin) throughout gestation and lactation did
not affect litter size, fetal development, postnatal sur-
vival, skeletal development or postnatal body weight of
the offspring. Flavonoid intake at these high levels were
associated with alterations in maternal and offspring liver
mineral content as well as lower offspring heart tissue
weights in the RU2 group compared to the EC1 group.
The reduction in liver copper and iron concentration in
the offspring supplemented with epicatechin is important
to note since long-term deﬁciency can result in adverse
developmental consequences. Similarly, the functional
consequences of lower hepatic calcium concentrations
in offspring supplemented with rutin need to be ascer-
tained. We  note that the ﬂavonoid intake level in our study
is approximately 28 times the highest reported human
intake. While dietary intake of ﬂavonoids in humans is
unlikely to reach these high levels, we purposely chose to
examine the chronic intakes of high amounts of ﬂavonoids
because the use of ﬂavonoid supplements could reach
or exceed these levels. The results from this study indi-
cate that high intakes of the ﬂavanols epicatechin and
catechin and the ﬂavonol rutin are not associated with
any overt developmental toxic effects but may  interact
with the metabolism of certain metals. Additional stud-
ies investigating the dose-response curve of ﬂavonoids on
hepatic mineral content and the effect on iron, copper, and
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calcium-dependent processes in the offspring are warran-
ted. The absence of developmental toxicity and the embryo
protective effects of ﬂavanol and ﬂavonol ingestion against
known reproductive toxicants in rodents shown by us
herein and by others, combined with previous reports of
potential health beneﬁts of ﬂavonoid ingestion in com-
plicated pregnancies, support that ﬂavonoid consumption
as part of a regular diet is largely beneﬁcial to pregnant
women  [46,49,50,59–62]. Translating the ﬁndings of this
animal study into recommendations for pregnant women
are limited but a cautious interpretation of the data from
this study indicates that the consumption of ﬂavonols and
ﬂavanols by pregnant women does not represent a risk.
Transparency document
The Transparency document associated with this article
can be found in the online version.
Acknowledgments
The authors would like to thank Dr. Janet Uriu-
Adams for her expertise and input on the writing of this
manuscript and Dr. Martin Lesser for his statistical exper-
tise and guidance with regard to data analysis. This work
was  supported by funding from the Vitamin Cases Con-
sumer Settlement Fund.
References
[1] J.W. Erdman Jr., et al., Flavonoids and heart health: proceedings of
the ILSI North America ﬂavonoids Workshop, May  31–June 1, 2005,
Washington, DC, J. Nutr. 137 (3 (Suppl. 1)) (2007) 718S–737S.
[2] G.R. Beecher, Overview of dietary ﬂavonoids: nomenclature, occur-
rence and intake, J. Nutr. 133 (10) (2003) 3248S–3254S.
[3] P. Knekt, et al., Flavonoid intake and risk of chronic diseases, Am. J.
Clin. Nutr. 76 (3) (2002) 560–568.
[4] H. Javed, et al., Rutin prevents cognitive impairments by ameliorat-
ing oxidative stress and neuroinﬂammation in rat model of sporadic
dementia of Alzheimer type, Neuroscience 210 (2012) 340–352.
[5] J. Kim, et al., Cocoa phytochemicals: recent advances in molecu-
lar mechanisms on health, Crit. Rev. Food Sci. Nutr. 54 (11) (2014)
1458–1472.
[6] L. Wang, et al., Dietary intake of selected ﬂavonols, ﬂavones, and
ﬂavonoid-rich foods and risk of cancer in middle-aged and older
women, Am.  J. Clin. Nutr. 89 (3) (2009) 905–912.
[7] A. Cassidy, et al., Habitual intake of ﬂavonoid subclasses and incident
hypertension in adults, Am. J. Clin. Nutr. 93 (2) (2011) 338–347.
[8] D.L. Katz, K. Doughty, A. Ali, Cocoa and chocolate in human health
and  disease, Antioxid. Redox Signal. 15 (10) (2011) 2779–2811.
[9] K.E. Heim, A.R. Tagliaferro, D.J. Bobilya, Flavonoid antioxidants:
chemistry, metabolism and structure-activity relationships, J. Nutr.
Biochem. 13 (10) (2002) 572–584.
10] J. Yang, et al., Antioxidant intervention of smoking-induced lung
tumor in mice by vitamin E and quercetin, BMC  Cancer 8 (2008) 383.
11] R. Olszanecki, et al., Flavonoids and nitric oxide synthase, J. Physiol.
Pharmacol. 53 (4 (Pt 1)) (2002) 571–584.
12] M.  Galleano, P.I. Oteiza, C.G. Fraga, Cocoa, chocolate, and cardiovas-
cular disease, J. Cardiovasc. Pharmacol. 54 (6) (2009) 483–490.
13] C. Selmi, et al., Chocolate at heart: the anti-inﬂammatory impact of
cocoa ﬂavanols, Mol. Nutr. Food Res. 52 (11) (2008) 1340–1348.
14] H. Schroeter, et al., (−)-Epicatechin mediates beneﬁcial effects of
ﬂavanol-rich cocoa on vascular function in humans, Proc. Natl. Acad.
Sci. USA 103 (4) (2006) 1024–1029.15] H. Schroeter, et al., Recommending ﬂavanols and procyanidins for
cardiovascular health: current knowledge and future needs, Mol.
Aspects Med. 31 (6) (2010) 546–557.
16] R. Jimenez, J. Duarte, F. Perez-Vizcaino, Epicatechin: endothelial
function and blood pressure, J. Agric. Food Chem. (2012).
ology Re
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
insulin-dependent glucose transporter 4 translocation, Mol. Nutr.M.N.R. Lesser et al. / Toxic
17] P.J. Mink, et al., Flavonoid intake and cardiovascular disease mortal-
ity: a prospective study in postmenopausal women, Am.  J. Clin. Nutr.
85 (3) (2007) 895–909.
18] M. Monagas, et al., Effect of cocoa powder on the modulation of
inﬂammatory biomarkers in patients at high risk of cardiovascular
disease, Am.  J. Clin. Nutr. 90 (5) (2009) 1144–1150.
19] K.D. Monahan, et al., Dose-dependent increases in ﬂow-mediated
dilation following acute cocoa ingestion in healthy older adults, J.
Appl. Physiol. 111 (6) (2011) 1568–1574.
20] E. Middleton Jr., C. Kandaswami, T.C. Theoharides, The effects of plant
ﬂavonoids on mammalian cells: implications for inﬂammation, heart
disease, and cancer, Pharmacol. Rev. 52 (4) (2000) 673–751.
21] H. Sugiyama, et al., Oligomeric procyanidins in apple polyphe-
nol  are main active components for inhibition of pancreatic lipase
and triglyceride absorption, J. Agric. Food Chem. 55 (11) (2007)
4604–4609.
22] L. Zhao, et al., Dietary quercetin supplementation increases serum
antioxidant capacity and alters hepatic gene expression proﬁle in
rats, Exp. Biol. Med. (Maywood) 236 (6) (2011) 701–706.
23] V. Kapadia, et al., Prenatal closure of the ductus arteriosus and mater-
nal ingestion of anthocyanins, J. Perinatol. 30 (4) (2010) 291–294.
24] P. Zielinsky, et al., Maternal consumption of polyphenol-rich foods in
late pregnancy and fetal ductus arteriosus ﬂow dynamics, J. Perinatol.
30  (1) (2010) 17–21.
25] J. Patera, et al., Morphometric and functional abnormalities of kid-
neys in the progeny of mice fed chocolate during pregnancy and
lactation, Folia Histochem. Cytobiol. 44 (3) (2006) 207–211.
26] K. Vanhees, et al., Intrauterine exposure to ﬂavonoids modiﬁes
antioxidant status at adulthood and decreases oxidative stress-
induced DNA damage, Free Radic. Biol. Med. 57 (2013) 154–161.
27] F. Giannandrea, Correlation analysis of cocoa consumption data with
worldwide incidence rates of testicular cancer and hypospadias, Int.
J.  Environ. Res. Public Health 6 (2) (2009) 568–578.
28] P. Skopinski, et al., Chocolate feeding of pregnant mice inﬂuences
length of limbs of their progeny, Pol. J. Vet. Sci. 6 (3 (Suppl.)) (2003)
57–59.
29] C. Kies, J. Umoren, Inhibitors of copper bioutilization: ﬁber, lead,
phytate and tannins, Adv. Exp. Med. Biol. 258 (1989) 81–93.
30] S.M. Kuo, P.S. Leavitt, C.P. Lin, Dietary ﬂavonoids interact with trace
metals and affect metallothionein level in human intestinal cells,
Biol. Trace Elem. Res. 62 (3) (1998) 135–153.
31] R. Strick, et al., Dietary bioﬂavonoids induce cleavage in the MLL  gene
and may  contribute to infant leukemia, Proc. Natl. Acad. Sci. USA 97
(9) (2000) 4790–4795.
32] J.A. Ross, Environmental and genetic susceptibility to MLL-deﬁned
infant leukemia, J. Natl. Cancer Inst. Monogr. (39) (2008) 83–86.
33] U.S. Department of Agriculture, USDA Database for the Flavonoid
Content of Selected Foods, 2003.
34] K.B. Miller, et al., Survey of commercially available chocolate- and
cocoa-containing products in the United States. 2. Comparison of
ﬂavan-3-ol content with nonfat cocoa solids, total polyphenols, and
percent cacao, J. Agric. Food Chem. 57 (19) (2009) 9169–9180.
35] M.S. Clegg, et al., Inﬂuence of ashing techniques in the analysis of
trace elements in animal tissue. I. Wet  ashing, Biol. Trace Elem. Res.
3  (1981) 107–115.
36] M. Inouye, Differentlal staining of cartilage and bone in fetal mouse
skeleton by Alcian Blue and Alizerin Red S, Congenit. Anom. 16 (1976)
171–173.
37] K.O. Chu, et al., Pharmacokinetic studies of green tea catechins in
maternal plasma and fetuses in rats, J. Pharm. Sci. 95 (6) (2006)
1372–1381.
38] K.O. Chu, et al., Uptake and distribution of catechins in fetal organs
following in utero exposure in rats, Hum. Reprod. 22 (1) (2007)
280–287.
39] H.C. Tu, C.P. Chen, W.H. Chan, Epicatechin gallate decreases the via-
bility and subsequent embryonic development of mouse blastocysts,
Taiwan J. Obstet. Gynecol. 49 (2) (2010) 174–180.
40] C.C. Wang, et al., Tea epigallocatechin-3-gallate increases 8-
isoprostane level and induces caudal regression in developing rat
embryos, Free Radic. Biol. Med. 43 (4) (2007) 519–527.
[ports 2 (2015) 443–449 449
41] C. Manach, et al., Bioavailability and bioefﬁcacy of polyphenols in
humans. I. Review of 97 bioavailability studies, Am.  J. Clin. Nutr. 81
(1 (Suppl.)) (2005) 230S–242S.
42] T. Makino, et al., Enzymatically modiﬁed isoquercitrin, alpha-
oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than
other quercetin glycosides or aglycone after oral administration in
rats, Biol. Pharm. Bull. 32 (12) (2009) 2034–2040.
43] J.I. Ottaviani, et al., The stereochemical conﬁguration of ﬂavanols
inﬂuences the level and metabolism of ﬂavanols in humans and
their biological activity in vivo, Free Radic. Biol. Med. 50 (2) (2011)
237–244.
44] J.I. Ottaviani, et al., Structurally related (−)-epicatechin metabo-
lites in humans: assessment using de novo chemically synthesized
authentic standards, Free Radic. Biol. Med. 52 (8) (2012) 1403–1412.
45] M.N. Clifford, J.J. van der Hooft, A. Crozier, Human studies on the
absorption, distribution, metabolism, and excretion of tea polyphe-
nols, Am.  J. Clin. Nutr. 98 (6 Suppl) (2013) 1619S–1630S.
46] A.L. Logsdon, et al., Exposure to green tea extract alters the incidence
of speciﬁc cyclophosphamide-induced malformations, Birth Defects
Res. B: Dev. Reprod. Toxicol. (2012).
47] O. Morita, et al., Effects of green tea catechin on embryo/fetal devel-
opment in rats, Food Chem. Toxicol. 47 (6) (2009) 1296–1303.
48] R.A. Isbrucker, et al., Safety studies on epigallocatechin gallate (EGCG)
preparations. Part 3: Teratogenicity and reproductive toxicity studies
in rats, Food Chem. Toxicol. 44 (5) (2006) 651–661.
49] M.R. Prater, et al., Placental oxidative stress alters expression of
murine osteogenic genes and impairs fetal skeletal formation, Pla-
centa 29 (9) (2008) 802–808.
50] R. Perez-Pasten, E. Martinez-Galero, G. Chamorro-Cevallos,
Quercetin and naringenin reduce abnormal development of mouse
embryos produced by hydroxyurea, J. Pharm. Pharmacol. 62 (8)
(2010) 1003–1009.
51] L. Bravo, Polyphenols: chemistry, dietary sources, metabolism, and
nutritional signiﬁcance, Nutr. Rev. 56 (11) (1998) 317–333.
52] M.W.  Taubeneck, et al., Altered maternal zinc metabolism following
exposure to diverse developmental toxicants, Reprod. Toxicol. 8 (1)
(1994) 25–40.
53] J.Y. Uriu-Adams, C.L. Keen, Zinc and reproduction: effects of zinc deﬁ-
ciency on prenatal and early postnatal development, Birth Defects
Res. B: Dev. Reprod. Toxicol. 89 (4) (2010) 313–325.
54] L. Gambling, H.J. McArdle, Iron, copper and fetal development, Proc.
Nutr. Soc. 63 (4) (2004) 553–562.
55] J.Y. Uriu-Adams, et al., Inﬂuence of copper on early development:
prenatal and postnatal considerations, Biofactors 36 (2) (2010)
136–152.
56] R.F. Hurrell, M.  Reddy, J.D. Cook, Inhibition of non-haem iron absorp-
tion in man  by polyphenolic-containing beverages, Br. J. Nutr. 81 (4)
(1999) 289–295.
57] R. Rucker, D. Storms, Interspecies comparisons of micronutrient
requirements: metabolic vs. absolute body size, J. Nutr. 132 (10)
(2002) 2999–3000.
58] R.B. Rucker, Allometric scaling, metabolic body size and interspecies
comparisons of basal nutritional requirements, J. Anim. Physiol.
Anim. Nutr. (Berl) 91 (3–4) (2007) 148–156.
59] H.M. Tanir, et al., Effect of quercetine and glutathione on the level
of  superoxide dismutase, catalase, malonyldialdehyde, blood pres-
sure and neonatal outcome in a rat model of pre-eclampsia induced
by NG-nitro-l-arginine-methyl ester, Eur. J. Obstet. Gynecol. Reprod.
Biol. 118 (2) (2005) 190–195.
60] J.A. Gonzalez-Garrido Chem, et al., Inﬂuence of the AT(2) receptor on
the  l-arginine-nitric oxide pathway and effects of (−)-epicatechin on
HUVECs from women with preeclampsia, J. Hum. Hypertens. 27 (6)
(2013) 355–361.
61] C.Y. Hsu, et al., Rutin potentiates insulin receptor kinase to enhanceFood Res. 58 (6) (2014) 1168–1176.
62] P.V. Babu, D. Liu, E.R. Gilbert, Recent advances in understanding the
anti-diabetic actions of dietary ﬂavonoids, J. Nutr. Biochem. 24 (11)
(2013) 1777–1789.
